{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T20:06:43Z","timestamp":1766088403023,"version":"3.40.5"},"reference-count":87,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"name":"the Joint Institute of Tobacco and Health","award":["2021539200340042"],"award-info":[{"award-number":["2021539200340042"]}]},{"name":"the Technology Innovation Talents Project of Yunnan Province","award":["202105AD160018"],"award-info":[{"award-number":["202105AD160018"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Appl Biochem Biotechnol"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1007\/s12010-024-05086-z","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T03:37:11Z","timestamp":1736998631000},"page":"3026-3047","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Nicotine Ameliorates \u03b1-Synuclein Preformed Fibril-Induced Behavioral Deficits and Pathological Features in Mice"],"prefix":"10.1007","volume":"197","author":[{"given":"Zhangqiong","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yue","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaili","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiyu","family":"Luo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qinglan","family":"Zong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengcun","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhouhai","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3393-8222","authenticated-orcid":false,"given":"Ying","family":"Guan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"issue":"6645","key":"5086_CR1","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1038\/42166","volume":"388","author":"MG Spillantini","year":"1997","unstructured":"Spillantini, M. G., Schmidt, M. L., Lee, V. M., Trojanowski, J. Q., Jakes, R., & Goedert, M. (1997). Alpha-synuclein in Lewy bodies. Nature, 388(6645), 839\u2013840. https:\/\/doi.org\/10.1038\/42166","journal-title":"Nature"},{"issue":"4","key":"5086_CR2","first-page":"879","volume":"152","author":"M Baba","year":"1998","unstructured":"Baba, M., Nakajo, S., Tu, P. H., Tomita, T., Nakaya, K., Lee, V. M., et al. (1998). Aggregation of alpha-synuclein in Lewy bodies of sporadic Parkinson\u2019s disease and dementia with Lewy bodies. American Journal of Pathology, 152(4), 879\u2013884.","journal-title":"American Journal of Pathology"},{"issue":"2","key":"5086_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/nm.4269","volume":"23","author":"YC Wong","year":"2017","unstructured":"Wong, Y. C., & Krainc, D. (2017). alpha-synuclein toxicity in neurodegeneration: Mechanism and therapeutic strategies. Nature Medicine, 23(2), 1\u201313. https:\/\/doi.org\/10.1038\/nm.4269","journal-title":"Nature Medicine"},{"issue":"5","key":"5086_CR4","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1007\/s00401-017-1746-2","volume":"134","author":"F Loria","year":"2017","unstructured":"Loria, F., Vargas, J. Y., Bousset, L., Syan, S., Salles, A., Melki, R., et al. (2017). alpha-Synuclein transfer between neurons and astrocytes indicates that astrocytes play a role in degradation rather than in spreading. Acta Neuropathologica, 134(5), 789\u2013808. https:\/\/doi.org\/10.1007\/s00401-017-1746-2","journal-title":"Acta Neuropathologica"},{"key":"5086_CR5","doi-asserted-by":"publisher","unstructured":"Kam, T. I., Mao, X., Park, H., Chou, S. C., Karuppagounder, S. S. & Umanah, G. E., et al. (2018). Poly(ADP-ribose) drives pathologic alpha-synuclein neurodegeneration in Parkinson\u2019s disease. Science, 362(6414). https:\/\/doi.org\/10.1126\/science.aat8407","DOI":"10.1126\/science.aat8407"},{"key":"5086_CR6","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1186\/s40478-014-0088-8","volume":"2","author":"M Masuda-Suzukake","year":"2014","unstructured":"Masuda-Suzukake, M., Nonaka, T., Hosokawa, M., Kubo, M., Shimozawa, A., Akiyama, H., et al. (2014). Pathological alpha-synuclein propagates through neural networks. Acta Neuropathologica Communications, 2, 88. https:\/\/doi.org\/10.1186\/s40478-014-0088-8","journal-title":"Acta Neuropathologica Communications"},{"key":"5086_CR7","doi-asserted-by":"publisher","first-page":"104623","DOI":"10.1016\/j.nbd.2019.104623","volume":"134","author":"C Mezias","year":"2020","unstructured":"Mezias, C., Rey, N., Brundin, P., & Raj, A. (2020). Neural connectivity predicts spreading of alpha-synuclein pathology in fibril-injected mouse models: Involvement of retrograde and anterograde axonal propagation. Neurobiology of Diseases, 134, 104623. https:\/\/doi.org\/10.1016\/j.nbd.2019.104623","journal-title":"Neurobiology of Diseases"},{"key":"5086_CR8","doi-asserted-by":"publisher","DOI":"10.1126\/science.1227157","volume-title":"Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice","author":"KC Luk","year":"2012","unstructured":"Luk, K. C., Kehm, V., Carroll, J., Zhang, B., O\u2019Brien, P., Trojanowski, J. Q., et al. (2012). Pathological \u03b1-synuclein transmission initiates Parkinson-like neurodegeneration in nontransgenic mice. Science."},{"issue":"1","key":"5086_CR9","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.neuron.2011.08.033","volume":"72","author":"LA Volpicelli-Daley","year":"2011","unstructured":"Volpicelli-Daley, L. A., Luk, K. C., Patel, T. P., Tanik, S. A., Riddle, D. M., Stieber, A., et al. (2011). Exogenous alpha-synuclein fibrils induce Lewy body pathology leading to synaptic dysfunction and neuron death. Neuron, 72(1), 57\u201371. https:\/\/doi.org\/10.1016\/j.neuron.2011.08.033","journal-title":"Neuron"},{"key":"5086_CR10","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1016\/j.nbd.2015.06.003","volume":"82","author":"KL Paumier","year":"2015","unstructured":"Paumier, K. L., Luk, K. C., Manfredsson, F. P., Kanaan, N. M., Lipton, J. W., Collier, T. J., et al. (2015). Intrastriatal injection of pre-formed mouse alpha-synuclein fibrils into rats triggers alpha-synuclein pathology and bilateral nigrostriatal degeneration. Neurobiology of Diseases, 82, 185\u2013199. https:\/\/doi.org\/10.1016\/j.nbd.2015.06.003","journal-title":"Neurobiology of Diseases"},{"issue":"4","key":"5086_CR11","doi-asserted-by":"publisher","first-page":"703","DOI":"10.3233\/JPD-160881","volume":"6","author":"Z Kurowska","year":"2016","unstructured":"Kurowska, Z., Kordower, J. H., Stoessl, A. J., Burke, R. E., Brundin, P., Yue, Z., et al. (2016). Is axonal degeneration a key early event in Parkinson\u2019s disease? Journal of Parkinson\u2019s Disease, 6(4), 703\u2013707. https:\/\/doi.org\/10.3233\/JPD-160881","journal-title":"Journal of Parkinson's Disease"},{"issue":"5","key":"5086_CR12","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1084\/jem.20112457","volume":"209","author":"KC Luk","year":"2012","unstructured":"Luk, K. C., Kehm, V. M., Zhang, B., O\u2019Brien, P., Trojanowski, J. Q., & Lee, V. M. (2012). Intracerebral inoculation of pathological alpha-synuclein initiates a rapidly progressive neurodegenerative alpha-synucleinopathy in mice. Journal of Experimental Medicine, 209(5), 975\u2013986. https:\/\/doi.org\/10.1084\/jem.20112457","journal-title":"Journal of Experimental Medicine"},{"issue":"11","key":"5086_CR13","doi-asserted-by":"publisher","first-page":"750","DOI":"10.1016\/j.tins.2016.09.003","volume":"39","author":"NP Visanji","year":"2016","unstructured":"Visanji, N. P., Brotchie, J. M., Kalia, L. V., Koprich, J. B., Tandon, A., Watts, J. C., et al. (2016). Alpha-synuclein-based animal models of Parkinson\u2019s disease: Challenges and opportunities in a new era. Trends in Neurosciences, 39(11), 750\u2013762. https:\/\/doi.org\/10.1016\/j.tins.2016.09.003","journal-title":"Trends in Neurosciences"},{"issue":"Suppl 1","key":"5086_CR14","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1111\/jnc.13750","volume":"139","author":"W Oertel","year":"2016","unstructured":"Oertel, W., & Schulz, J. B. (2016). Current and experimental treatments of Parkinson disease: A guide for neuroscientists. Journal of Neurochemistry, 139(Suppl 1), 325\u2013337. https:\/\/doi.org\/10.1111\/jnc.13750","journal-title":"Journal of Neurochemistry"},{"issue":"2","key":"5086_CR15","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/s00213-014-3685-0","volume":"232","author":"A Cohen","year":"2015","unstructured":"Cohen, A., Soleiman, M. T., Talia, R., Koob, G. F., George, O., & Mandyam, C. D. (2015). Extended access nicotine self-administration with periodic deprivation increases immature neurons in the hippocampus. Psychopharmacology (Berl), 232(2), 453\u2013463. https:\/\/doi.org\/10.1007\/s00213-014-3685-0","journal-title":"Psychopharmacology (Berl)"},{"issue":"6","key":"5086_CR16","doi-asserted-by":"publisher","first-page":"1743","DOI":"10.1111\/adb.12437","volume":"22","author":"DB Vazquez-Sanroman","year":"2017","unstructured":"Vazquez-Sanroman, D. B., Monje, R. D., & Bardo, M. T. (2017). Nicotine self-administration remodels perineuronal nets in ventral tegmental area and orbitofrontal cortex in adult male rats. Addiction Biology, 22(6), 1743\u20131755. https:\/\/doi.org\/10.1111\/adb.12437","journal-title":"Addiction Biology"},{"key":"5086_CR17","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1016\/j.drugalcdep.2018.04.027","volume":"189","author":"L Carboni","year":"2018","unstructured":"Carboni, L., Romoli, B., Bate, S. T., Romualdi, P., & Zoli, M. (2018). Increased expression of CRF and CRF-receptors in dorsal striatum, hippocampus, and prefrontal cortex after the development of nicotine sensitization in rats. Drug and Alcohol Dependence, 189, 12\u201320. https:\/\/doi.org\/10.1016\/j.drugalcdep.2018.04.027","journal-title":"Drug and Alcohol Dependence"},{"issue":"6","key":"5086_CR18","doi-asserted-by":"publisher","first-page":"1176","DOI":"10.1124\/mol.113.084863","volume":"83","author":"G Collo","year":"2013","unstructured":"Collo, G., Bono, F., Cavalleri, L., Plebani, L., Mitola, S., Merlo, P. E., et al. (2013). Nicotine-induced structural plasticity in mesencephalic dopaminergic neurons is mediated by dopamine D3 receptors and Akt-mTORC1 signaling. Molecular Pharmacology, 83(6), 1176\u20131189. https:\/\/doi.org\/10.1124\/mol.113.084863","journal-title":"Molecular Pharmacology"},{"key":"5086_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.pneurobio.2014.10.002","volume":"124","author":"F Pistillo","year":"2015","unstructured":"Pistillo, F., Clementi, F., Zoli, M., & Gotti, C. (2015). Nicotinic, glutamatergic and dopaminergic synaptic transmission and plasticity in the mesocorticolimbic system: Focus on nicotine effects. Progress in Neurobiology, 124, 1\u201327. https:\/\/doi.org\/10.1016\/j.pneurobio.2014.10.002","journal-title":"Progress in Neurobiology"},{"issue":"2","key":"5086_CR20","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1016\/j.expneurol.2007.03.002","volume":"205","author":"K Ono","year":"2007","unstructured":"Ono, K., Hirohata, M., & Yamada, M. (2007). Anti-fibrillogenic and fibril-destabilizing activity of nicotine in vitro: Implications for the prevention and therapeutics of Lewy body diseases. Experimental Neurology, 205(2), 414\u2013424. https:\/\/doi.org\/10.1016\/j.expneurol.2007.03.002","journal-title":"Experimental Neurology"},{"issue":"2","key":"5086_CR21","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1016\/j.bbapap.2008.09.026","volume":"1794","author":"DP Hong","year":"2009","unstructured":"Hong, D. P., Fink, A. L., & Uversky, V. N. (2009). Smoking and Parkinson\u2019s disease: Does nicotine affect alpha-synuclein fibrillation? Biochimica et Biophysica Acta, 1794(2), 282\u2013290. https:\/\/doi.org\/10.1016\/j.bbapap.2008.09.026","journal-title":"Biochimica et Biophysica Acta"},{"issue":"6","key":"5086_CR22","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.bbadis.2017.02.002","volume":"1863","author":"J Kardani","year":"2017","unstructured":"Kardani, J., Sethi, R., & Roy, I. (2017). Nicotine slows down oligomerisation of alpha-synuclein and ameliorates cytotoxicity in a yeast model of Parkinson\u2019s disease. Biochimica et Biophysica Acta, Molecular Basis of Disease, 1863(6), 1454\u20131463. https:\/\/doi.org\/10.1016\/j.bbadis.2017.02.002","journal-title":"Biochimica et Biophysica Acta, Molecular Basis of Disease"},{"issue":"2","key":"5086_CR23","doi-asserted-by":"publisher","first-page":"414","DOI":"10.1006\/exnr.1999.7106","volume":"158","author":"EF Domino","year":"1999","unstructured":"Domino, E. F., Ni, L., & Zhang, H. (1999). Nicotine alone and in combination with L-DOPA methyl ester or the D(2) agonist N-0923 in MPTP-induced chronic hemiparkinsonian monkeys. Experimental Neurology, 158(2), 414\u2013421. https:\/\/doi.org\/10.1006\/exnr.1999.7106","journal-title":"Experimental Neurology"},{"issue":"3","key":"5086_CR24","doi-asserted-by":"publisher","first-page":"932","DOI":"10.1124\/jpet.111.182949","volume":"338","author":"LZ Huang","year":"2011","unstructured":"Huang, L. Z., Grady, S. R., & Quik, M. (2011). Nicotine reduces L-DOPA-induced dyskinesias by acting at beta2* nicotinic receptors. Journal of Pharmacology and Experimental Therapeutics, 338(3), 932\u2013941. https:\/\/doi.org\/10.1124\/jpet.111.182949","journal-title":"Journal of Pharmacology and Experimental Therapeutics"},{"issue":"8","key":"5086_CR25","doi-asserted-by":"publisher","first-page":"947","DOI":"10.1002\/mds.25028","volume":"27","author":"M Quik","year":"2012","unstructured":"Quik, M., Perez, X. A., & Bordia, T. (2012). Nicotine as a potential neuroprotective agent for Parkinson\u2019s disease. Movement Disorders, 27(8), 947\u2013957. https:\/\/doi.org\/10.1002\/mds.25028","journal-title":"Movement Disorders"},{"issue":"2","key":"5086_CR26","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/s0006-8993(00)03087-0","volume":"888","author":"G Costa","year":"2001","unstructured":"Costa, G., Abin-Carriquiry, J. A., & Dajas, F. (2001). Nicotine prevents striatal dopamine loss produced by 6-hydroxydopamine lesion in the substantia nigra. Brain Research, 888(2), 336\u2013342. https:\/\/doi.org\/10.1016\/s0006-8993(00)03087-0","journal-title":"Brain Research"},{"issue":"4\u20135","key":"5086_CR27","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/s0161-813x(02)00036-0","volume":"23","author":"M Quik","year":"2002","unstructured":"Quik, M., & Kulak, J. M. (2002). Nicotine and nicotinic receptors; relevance to Parkinson\u2019s disease. Neurotoxicology, 23(4\u20135), 581\u2013594. https:\/\/doi.org\/10.1016\/s0161-813x(02)00036-0","journal-title":"Neurotoxicology"},{"issue":"2","key":"5086_CR28","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1097\/WNF.0b013e31827fd9cd","volume":"36","author":"WT Kyaw","year":"2013","unstructured":"Kyaw, W. T., Nagai, M., Kaneta, M., Kubo, M., Nishikawa, N., Tsujii, T., et al. (2013). Effect of nicotine on the pharmacokinetics of levodopa. Clinical Neuropharmacology, 36(2), 46\u201351. https:\/\/doi.org\/10.1097\/WNF.0b013e31827fd9cd","journal-title":"Clinical Neuropharmacology"},{"key":"5086_CR29","doi-asserted-by":"publisher","first-page":"340","DOI":"10.3389\/fnagi.2014.00340","volume":"6","author":"GE Barreto","year":"2014","unstructured":"Barreto, G. E., Iarkov, A., & Moran, V. E. (2014). Beneficial effects of nicotine, cotinine and its metabolites as potential agents for Parkinson\u2019s disease. Front Aging Neurosci, 6, 340. https:\/\/doi.org\/10.3389\/fnagi.2014.00340","journal-title":"Front Aging Neurosci"},{"issue":"1","key":"5086_CR30","doi-asserted-by":"publisher","first-page":"9579","DOI":"10.1038\/s41598-021-88910-4","volume":"11","author":"A Carvajal-Oliveros","year":"2021","unstructured":"Carvajal-Oliveros, A., Dominguez-Baleon, C., Zarate, R. V., Campusano, J. M., Narvaez-Padilla, V., & Reynaud, E. (2021). Nicotine suppresses Parkinson\u2019s disease like phenotypes induced by synphilin-1 overexpression in Drosophila melanogaster by increasing tyrosine hydroxylase and dopamine levels. Science and Reports, 11(1), 9579. https:\/\/doi.org\/10.1038\/s41598-021-88910-4","journal-title":"Science and Reports"},{"issue":"9","key":"5086_CR31","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1212\/wnl.41.9.1402","volume":"41","author":"DW Dickson","year":"1991","unstructured":"Dickson, D. W., Ruan, D., Crystal, H., Mark, M. H., Davies, P., Kress, Y., et al. (1991). Hippocampal degeneration differentiates diffuse Lewy body disease (DLBD) from Alzheimer\u2019s disease: Light and electron microscopic immunocytochemistry of CA2-3 neurites specific to DLBD. Neurology, 41(9), 1402\u20131409. https:\/\/doi.org\/10.1212\/wnl.41.9.1402","journal-title":"Neurology"},{"key":"5086_CR32","doi-asserted-by":"publisher","first-page":"S221","DOI":"10.1016\/S1353-8020(08)70005-1","volume":"13","author":"Y Tsuboi","year":"2007","unstructured":"Tsuboi, Y., Uchikado, H., & Dickson, D. W. (2007). Neuropathology of Parkinson\u2019s disease dementia and dementia with Lewy bodies with reference to striatal pathology. Parkinsonism & Related Disorders, 13, S221\u2013S224.","journal-title":"Parkinsonism & Related Disorders"},{"issue":"4","key":"5086_CR33","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1007\/s00401-008-0344-8","volume":"115","author":"G Halliday","year":"2008","unstructured":"Halliday, G., Hely, M., Reid, W., & Morris, J. (2008). The progression of pathology in longitudinally followed patients with Parkinson\u2019s disease. Acta Neuropathologica, 115(4), 409\u2013415. https:\/\/doi.org\/10.1007\/s00401-008-0344-8","journal-title":"Acta Neuropathologica"},{"issue":"1","key":"5086_CR34","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/S1474-4422(16)30291-5","volume":"16","author":"DJ Irwin","year":"2017","unstructured":"Irwin, D. J., Grossman, M., Weintraub, D., Hurtig, H. I., Duda, J. E., Xie, S. X., et al. (2017). Neuropathological and genetic correlates of survival and dementia onset in synucleinopathies: A retrospective analysis. Lancet Neurology, 16(1), 55\u201365. https:\/\/doi.org\/10.1016\/S1474-4422(16)30291-5","journal-title":"Lancet Neurology"},{"issue":"8","key":"5086_CR35","doi-asserted-by":"publisher","first-page":"811","DOI":"10.1016\/S1474-4422(13)70118-2","volume":"12","author":"P Calabresi","year":"2013","unstructured":"Calabresi, P., Castrioto, A., Di Filippo, M., & Picconi, B. (2013). New experimental and clinical links between the hippocampus and the dopaminergic system in Parkinson\u2019s disease. Lancet Neurology, 12(8), 811\u2013821. https:\/\/doi.org\/10.1016\/S1474-4422(13)70118-2","journal-title":"Lancet Neurology"},{"issue":"7","key":"5086_CR36","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.biopsych.2013.11.020","volume":"75","author":"MN Braskie","year":"2014","unstructured":"Braskie, M. N., & Thompson, P. M. (2014). A focus on structural brain imaging in the Alzheimer\u2019s disease neuroimaging initiative. Biological Psychiatry, 75(7), 527\u2013533. https:\/\/doi.org\/10.1016\/j.biopsych.2013.11.020","journal-title":"Biological Psychiatry"},{"key":"5086_CR37","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1016\/j.neuroimage.2015.03.035","volume":"112","author":"MA Fraser","year":"2015","unstructured":"Fraser, M. A., Shaw, M. E., & Cherbuin, N. (2015). A systematic review and meta-analysis of longitudinal hippocampal atrophy in healthy human ageing. NeuroImage, 112, 364\u2013374. https:\/\/doi.org\/10.1016\/j.neuroimage.2015.03.035","journal-title":"NeuroImage"},{"key":"5086_CR38","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.arr.2016.01.002","volume":"30","author":"L Pini","year":"2016","unstructured":"Pini, L., Pievani, M., Bocchetta, M., Altomare, D., Bosco, P., Cavedo, E., et al. (2016). Brain atrophy in Alzheimer\u2019s disease and aging. Ageing Research Reviews, 30, 25\u201348. https:\/\/doi.org\/10.1016\/j.arr.2016.01.002","journal-title":"Ageing Research Reviews"},{"key":"5086_CR39","doi-asserted-by":"publisher","first-page":"226","DOI":"10.1016\/j.bbi.2021.03.020","volume":"95","author":"T Du","year":"2021","unstructured":"Du, T., Li, G., Luo, H., Pan, Y., Xu, Q., & Ma, K. (2021). Hippocampal alpha-synuclein mediates depressive-like behaviors. Brain, Behavior, and Immunity, 95, 226\u2013237. https:\/\/doi.org\/10.1016\/j.bbi.2021.03.020","journal-title":"Brain, Behavior, and Immunity"},{"issue":"2","key":"5086_CR40","doi-asserted-by":"publisher","first-page":"829","DOI":"10.1007\/s00429-018-1799-6","volume":"224","author":"SL Otto","year":"2019","unstructured":"Otto, S. L., & Yakel, J. L. (2019). The alpha7 nicotinic acetylcholine receptors regulate hippocampal adult-neurogenesis in a sexually dimorphic fashion. Brain Structure & Function, 224(2), 829\u2013846. https:\/\/doi.org\/10.1007\/s00429-018-1799-6","journal-title":"Brain Structure & Function"},{"issue":"26","key":"5086_CR41","doi-asserted-by":"publisher","first-page":"8734","DOI":"10.1523\/JNEUROSCI.0931-10.2010","volume":"30","author":"NR Campbell","year":"2010","unstructured":"Campbell, N. R., Fernandes, C. C., Halff, A. W., & Berg, D. K. (2010). Endogenous signaling through alpha7-containing nicotinic receptors promotes maturation and integration of adult-born neurons in the hippocampus. Journal of Neuroscience, 30(26), 8734\u20138744. https:\/\/doi.org\/10.1523\/JNEUROSCI.0931-10.2010","journal-title":"Journal of Neuroscience"},{"issue":"3","key":"5086_CR42","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1089\/scd.2010.0326","volume":"21","author":"Z Wei","year":"2012","unstructured":"Wei, Z., Belal, C., Tu, W., Chigurupati, S., Ameli, N. J., Lu, Y., et al. (2012). Chronic nicotine administration impairs activation of cyclic AMP-response element binding protein and survival of newborn cells in the dentate gyrus. Stem Cells Dev, 21(3), 411\u2013422. https:\/\/doi.org\/10.1089\/scd.2010.0326","journal-title":"Stem Cells Dev"},{"key":"5086_CR43","doi-asserted-by":"publisher","first-page":"170","DOI":"10.1016\/j.nbd.2018.05.018","volume":"117","author":"SR Subramaniam","year":"2018","unstructured":"Subramaniam, S. R., Magen, I., Bove, N., Zhu, C., Lemesre, V., Dutta, G., et al. (2018). Chronic nicotine improves cognitive and social impairment in mice overexpressing wild type alpha-synuclein. Neurobiology of Diseases, 117, 170\u2013180. https:\/\/doi.org\/10.1016\/j.nbd.2018.05.018","journal-title":"Neurobiology of Diseases"},{"key":"5086_CR44","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1007\/978-1-4939-8994-2_10","volume":"1916","author":"AK Kraeuter","year":"2019","unstructured":"Kraeuter, A. K., Guest, P. C., & Sarnyai, Z. (2019). The Y-maze for assessment of spatial working and reference memory in mice. Methods in Molecular Biology, 1916, 105\u2013111. https:\/\/doi.org\/10.1007\/978-1-4939-8994-2_10","journal-title":"Methods in Molecular Biology"},{"issue":"1","key":"5086_CR45","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/s12933-021-01231-8","volume":"20","author":"EL Saw","year":"2021","unstructured":"Saw, E. L., Pearson, J. T., Schwenke, D. O., Munasinghe, P. E., Tsuchimochi, H., Rawal, S., et al. (2021). Activation of the cardiac non-neuronal cholinergic system prevents the development of diabetes-associated cardiovascular complications. Cardiovascular Diabetology, 20(1), 50. https:\/\/doi.org\/10.1186\/s12933-021-01231-8","journal-title":"Cardiovascular Diabetology"},{"key":"5086_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","volume":"147","author":"RC Hogg","year":"2003","unstructured":"Hogg, R. C., Raggenbass, M., & Bertrand, D. (2003). Nicotinic acetylcholine receptors: From structure to brain function. Reviews of Physiology Biochemistry and Pharmacology, 147, 1\u201346. https:\/\/doi.org\/10.1007\/s10254-003-0005-1","journal-title":"Reviews of Physiology Biochemistry and Pharmacology"},{"issue":"40","key":"5086_CR47","doi-asserted-by":"publisher","first-page":"29739","DOI":"10.1074\/jbc.M600933200","volume":"281","author":"JP Anderson","year":"2006","unstructured":"Anderson, J. P., Walker, D. E., Goldstein, J. M., de Laat, R., Banducci, K., Caccavello, R. J., et al. (2006). Phosphorylation of Ser-129 is the dominant pathological modification of alpha-synuclein in familial and sporadic Lewy body disease. Journal of Biological Chemistry, 281(40), 29739\u201329752. https:\/\/doi.org\/10.1074\/jbc.M600933200","journal-title":"Journal of Biological Chemistry"},{"issue":"4","key":"5086_CR48","doi-asserted-by":"publisher","first-page":"431","DOI":"10.1007\/s00281-010-0220-1","volume":"32","author":"Y Ichimura","year":"2010","unstructured":"Ichimura, Y., & Komatsu, M. (2010). Selective degradation of p62 by autophagy. Semin Immunopathol, 32(4), 431\u2013436. https:\/\/doi.org\/10.1007\/s00281-010-0220-1","journal-title":"Semin Immunopathol"},{"issue":"8","key":"5086_CR49","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.tcm.2012.05.015","volume":"21","author":"H Su","year":"2011","unstructured":"Su, H., & Wang, X. (2011). p62 Stages an interplay between the ubiquitin-proteasome system and autophagy in the heart of defense against proteotoxic stress. Trends in Cardiovascular Medicine, 21(8), 224\u2013228. https:\/\/doi.org\/10.1016\/j.tcm.2012.05.015","journal-title":"Trends in Cardiovascular Medicine"},{"issue":"Pt A","key":"5086_CR50","doi-asserted-by":"publisher","first-page":"172","DOI":"10.1016\/j.expneurol.2017.10.017","volume":"299","author":"N Nouraei","year":"2018","unstructured":"Nouraei, N., Mason, D. M., Miner, K. M., Carcella, M. A., Bhatia, T. N., Dumm, B. K., et al. (2018). Critical appraisal of pathology transmission in the alpha-synuclein fibril model of Lewy body disorders. Experimental Neurology, 299(Pt A), 172\u2013196. https:\/\/doi.org\/10.1016\/j.expneurol.2017.10.017","journal-title":"Experimental Neurology"},{"key":"5086_CR51","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1007\/978-1-4939-9124-2_5","volume":"1948","author":"B Zhang","year":"2019","unstructured":"Zhang, B., Kehm, V., Gathagan, R., Leight, S. N., Trojanowski, J. Q., Lee, V. M., et al. (2019). Stereotaxic targeting of alpha-synuclein pathology in mouse brain using preformed fibrils. Methods in Molecular Biology, 1948, 45\u201357. https:\/\/doi.org\/10.1007\/978-1-4939-9124-2_5","journal-title":"Methods in Molecular Biology"},{"issue":"2","key":"5086_CR52","doi-asserted-by":"publisher","first-page":"303","DOI":"10.3233\/JPD-171248","volume":"8","author":"NK Polinski","year":"2018","unstructured":"Polinski, N. K., Volpicelli-Daley, L. A., Sortwell, C. E., Luk, K. C., Cremades, N., Gottler, L. M., et al. (2018). Best practices for generating and using alpha-synuclein pre-formed fibrils to model Parkinson\u2019s disease in rodents. Journal of Parkinson\u2019s Disease, 8(2), 303\u2013322. https:\/\/doi.org\/10.3233\/JPD-171248","journal-title":"Journal of Parkinson's Disease"},{"issue":"2\u20133","key":"5086_CR53","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1007\/s00213-004-2007-3","volume":"178","author":"SD Grabus","year":"2005","unstructured":"Grabus, S. D., Martin, B. R., Batman, A. M., Tyndale, R. F., Sellers, E., & Damaj, M. I. (2005). Nicotine physical dependence and tolerance in the mouse following chronic oral administration. Psychopharmacology (Berl), 178(2\u20133), 183\u2013192. https:\/\/doi.org\/10.1007\/s00213-004-2007-3","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"5086_CR54","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1007\/s00213-006-0441-0","volume":"190","author":"SG Matta","year":"2007","unstructured":"Matta, S. G., Balfour, D. J., Benowitz, N. L., Boyd, R. T., Buccafusco, J. J., Caggiula, A. R., et al. (2007). Guidelines on nicotine dose selection for in vivo research. Psychopharmacology (Berl), 190(3), 269\u2013319. https:\/\/doi.org\/10.1007\/s00213-006-0441-0","journal-title":"Psychopharmacology (Berl)"},{"key":"5086_CR55","doi-asserted-by":"publisher","first-page":"6770","DOI":"10.1038\/ncomms7770","volume":"6","author":"R Zhao-Shea","year":"2015","unstructured":"Zhao-Shea, R., DeGroot, S. R., Liu, L., Vallaster, M., Pang, X., Su, Q., et al. (2015). Increased CRF signalling in a ventral tegmental area-interpeduncular nucleus-medial habenula circuit induces anxiety during nicotine withdrawal. Nature Communications, 6, 6770. https:\/\/doi.org\/10.1038\/ncomms7770","journal-title":"Nature Communications"},{"key":"5086_CR56","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.neuropharm.2018.04.010","volume":"135","author":"C Mojica","year":"2018","unstructured":"Mojica, C., Bai, Y., & Lotfipour, S. (2018). Maternal nicotine exposure effects on adolescent learning and memory are abolished in alpha(alpha)2* nicotinic acetylcholine receptor-null mutant mice. Neuropharmacology, 135, 529\u2013535. https:\/\/doi.org\/10.1016\/j.neuropharm.2018.04.010","journal-title":"Neuropharmacology"},{"issue":"1","key":"5086_CR57","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1124\/pr.57.1.3","volume":"57","author":"J Hukkanen","year":"2005","unstructured":"Hukkanen, J., Jacob, P. R., & Benowitz, N. L. (2005). Metabolism and disposition kinetics of nicotine. Pharmacological Reviews, 57(1), 79\u2013115. https:\/\/doi.org\/10.1124\/pr.57.1.3","journal-title":"Pharmacological Reviews"},{"issue":"1","key":"5086_CR58","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1093\/ntr\/ntt105","volume":"16","author":"SD Alsharari","year":"2014","unstructured":"Alsharari, S. D., Siu, E. C., Tyndale, R. F., & Damaj, M. I. (2014). Pharmacokinetic and pharmacodynamics studies of nicotine after oral administration in mice: Effects of methoxsalen, a CYP2A5\/6 inhibitor. Nicotine & Tobacco Research, 16(1), 18\u201325. https:\/\/doi.org\/10.1093\/ntr\/ntt105","journal-title":"Nicotine & Tobacco Research"},{"issue":"1","key":"5086_CR59","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1038\/s41467-023-36543-8","volume":"14","author":"L Yang","year":"2023","unstructured":"Yang, L., Shen, J., Liu, C., Kuang, Z., Tang, Y., Qian, Z., et al. (2023). Nicotine rebalances NAD(+) homeostasis and improves aging-related symptoms in male mice by enhancing NAMPT activity. Nature Communications, 14(1), 900. https:\/\/doi.org\/10.1038\/s41467-023-36543-8","journal-title":"Nature Communications"},{"key":"5086_CR60","doi-asserted-by":"publisher","first-page":"637319","DOI":"10.3389\/fcell.2021.637319","volume":"9","author":"J Zhao","year":"2021","unstructured":"Zhao, J., Li, Y., Li, Y., Xu, S., Tao, T., Hua, Y., et al. (2021). Activation of alpha7-nAChRs promotes the clearance of alpha-synuclein and protects against apoptotic cell death induced by exogenous alpha-synuclein fibrils. Front Cell Dev Biol, 9, 637319. https:\/\/doi.org\/10.3389\/fcell.2021.637319","journal-title":"Front Cell Dev Biol"},{"issue":"3","key":"5086_CR61","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1177\/1073858418783959","volume":"25","author":"MK Jha","year":"2019","unstructured":"Jha, M. K., Jo, M., Kim, J. H., & Suk, K. (2019). Microglia-astrocyte crosstalk: An intimate molecular conversation. The Neuroscientist, 25(3), 227\u2013240. https:\/\/doi.org\/10.1177\/1073858418783959","journal-title":"The Neuroscientist"},{"issue":"15","key":"5086_CR62","doi-asserted-by":"publisher","first-page":"2150","DOI":"10.3748\/wjg.v13.i15.2150","volume":"13","author":"A Karban","year":"2007","unstructured":"Karban, A., & Eliakim, R. (2007). Effect of smoking on inflammatory bowel disease: Is it disease or organ specific? World Journal of Gastroenterology, 13(15), 2150\u20132152. https:\/\/doi.org\/10.3748\/wjg.v13.i15.2150","journal-title":"World Journal of Gastroenterology"},{"issue":"12","key":"5086_CR63","doi-asserted-by":"publisher","first-page":"2138","DOI":"10.1086\/430323","volume":"191","author":"DJ van Westerloo","year":"2005","unstructured":"van Westerloo, D. J., Giebelen, I. A., Florquin, S., Daalhuisen, J., Bruno, M. J., de Vos, A. F., et al. (2005). The cholinergic anti-inflammatory pathway regulates the host response during septic peritonitis. Journal of Infectious Diseases, 191(12), 2138\u20132148. https:\/\/doi.org\/10.1086\/430323","journal-title":"Journal of Infectious Diseases"},{"key":"5086_CR64","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1186\/1742-2094-9-98","volume":"9","author":"Y Liu","year":"2012","unstructured":"Liu, Y., Hu, J., Wu, J., Zhu, C., Hui, Y., Han, Y., et al. (2012). alpha7 nicotinic acetylcholine receptor-mediated neuroprotection against dopaminergic neuron loss in an MPTP mouse model via inhibition of astrocyte activation. Journal of Neuroinflammation, 9, 98. https:\/\/doi.org\/10.1186\/1742-2094-9-98","journal-title":"Journal of Neuroinflammation"},{"issue":"6921","key":"5086_CR65","doi-asserted-by":"publisher","first-page":"384","DOI":"10.1038\/nature01339","volume":"421","author":"H Wang","year":"2003","unstructured":"Wang, H., Yu, M., Ochani, M., Amella, C. A., Tanovic, M., Susarla, S., et al. (2003). Nicotinic acetylcholine receptor alpha7 subunit is an essential regulator of inflammation. Nature, 421(6921), 384\u2013388. https:\/\/doi.org\/10.1038\/nature01339","journal-title":"Nature"},{"issue":"1","key":"5086_CR66","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1111\/j.1460-9568.2007.05636.x","volume":"26","author":"HJ Park","year":"2007","unstructured":"Park, H. J., Lee, P. H., Ahn, Y. W., Choi, Y. J., Lee, G., Lee, D. Y., et al. (2007). Neuroprotective effect of nicotine on dopaminergic neurons by anti-inflammatory action. European Journal of Neuroscience, 26(1), 79\u201389. https:\/\/doi.org\/10.1111\/j.1460-9568.2007.05636.x","journal-title":"European Journal of Neuroscience"},{"issue":"4","key":"5086_CR67","doi-asserted-by":"publisher","first-page":"997","DOI":"10.1002\/stem.2266","volume":"34","author":"E Gebara","year":"2016","unstructured":"Gebara, E., Bonaguidi, M. A., Beckervordersandforth, R., Sultan, S., Udry, F., Gijs, P. J., et al. (2016). Heterogeneity of radial glia-like cells in the adult hippocampus. Stem Cells, 34(4), 997\u20131010. https:\/\/doi.org\/10.1002\/stem.2266","journal-title":"Stem Cells"},{"issue":"2","key":"5086_CR68","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1002\/jnr.21869","volume":"87","author":"H Takeuchi","year":"2009","unstructured":"Takeuchi, H., Yanagida, T., Inden, M., Takata, K., Kitamura, Y., Yamakawa, K., et al. (2009). Nicotinic receptor stimulation protects nigral dopaminergic neurons in rotenone-induced Parkinson\u2019s disease models. Journal of Neuroscience Research, 87(2), 576\u2013585. https:\/\/doi.org\/10.1002\/jnr.21869","journal-title":"Journal of Neuroscience Research"},{"issue":"1","key":"5086_CR69","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1523\/JNEUROSCI.2126-15.2016","volume":"36","author":"R Srinivasan","year":"2016","unstructured":"Srinivasan, R., Henley, B. M., Henderson, B. J., Indersmitten, T., Cohen, B. N., Kim, C. H., et al. (2016). Smoking-relevant nicotine concentration attenuates the unfolded protein response in dopaminergic neurons. Journal of Neuroscience, 36(1), 65\u201379. https:\/\/doi.org\/10.1523\/JNEUROSCI.2126-15.2016","journal-title":"Journal of Neuroscience"},{"issue":"5","key":"5086_CR70","doi-asserted-by":"publisher","first-page":"623","DOI":"10.2174\/138945012800399026","volume":"13","author":"J Kawamata","year":"2012","unstructured":"Kawamata, J., Suzuki, S., & Shimohama, S. (2012). Alpha7 nicotinic acetylcholine receptor mediated neuroprotection in Parkinson\u2019s disease. Current Drug Targets, 13(5), 623\u2013630. https:\/\/doi.org\/10.2174\/138945012800399026","journal-title":"Current Drug Targets"},{"issue":"7181","key":"5086_CR71","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1038\/nature06562","volume":"451","author":"CL Zhang","year":"2008","unstructured":"Zhang, C. L., Zou, Y., He, W., Gage, F. H., & Evans, R. M. (2008). A role for adult TLX-positive neural stem cells in learning and behaviour. Nature, 451(7181), 1004\u20131007. https:\/\/doi.org\/10.1038\/nature06562","journal-title":"Nature"},{"key":"5086_CR72","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1146\/annurev.psych.48.1.649","volume":"48","author":"BJ Everitt","year":"1997","unstructured":"Everitt, B. J., & Robbins, T. W. (1997). Central cholinergic systems and cognition. Annual Review of Psychology, 48, 649\u2013684. https:\/\/doi.org\/10.1146\/annurev.psych.48.1.649","journal-title":"Annual Review of Psychology"},{"issue":"1\u20132","key":"5086_CR73","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jns.2007.02.014","volume":"256","author":"N Oishi","year":"2007","unstructured":"Oishi, N., Hashikawa, K., Yoshida, H., Ishizu, K., Ueda, M., Kawashima, H., et al. (2007). Quantification of nicotinic acetylcholine receptors in Parkinson\u2019s disease with (123)I-5IA SPECT. Journal of the Neurological Sciences, 256(1\u20132), 52\u201360. https:\/\/doi.org\/10.1016\/j.jns.2007.02.014","journal-title":"Journal of the Neurological Sciences"},{"issue":"12","key":"5086_CR74","doi-asserted-by":"publisher","first-page":"1686","DOI":"10.1038\/s41593-021-00949-8","volume":"24","author":"K Zhang","year":"2021","unstructured":"Zhang, K., Forster, R., He, W., Liao, X., Li, J., Yang, C., et al. (2021). Fear learning induces alpha7-nicotinic acetylcholine receptor-mediated astrocytic responsiveness that is required for memory persistence. Nature Neuroscience, 24(12), 1686\u20131698. https:\/\/doi.org\/10.1038\/s41593-021-00949-8","journal-title":"Nature Neuroscience"},{"key":"5086_CR75","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.schres.2018.10.027","volume":"207","author":"UM Mehta","year":"2019","unstructured":"Mehta, U. M., Thanki, M. V., Padmanabhan, J., Pascual-Leone, A., & Keshavan, M. S. (2019). Motor cortical plasticity in schizophrenia: A meta-analysis of transcranial magnetic stimulation - electromyography studies. Schizophrenia Research, 207, 37\u201347. https:\/\/doi.org\/10.1016\/j.schres.2018.10.027","journal-title":"Schizophrenia Research"},{"issue":"1","key":"5086_CR76","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1007\/s12640-018-9931-1","volume":"35","author":"C Mouhape","year":"2019","unstructured":"Mouhape, C., Costa, G., Ferreira, M., Abin-Carriquiry, J. A., Dajas, F., & Prunell, G. (2019). Nicotine-induced neuroprotection in rotenone in vivo and in vitro models of Parkinson\u2019s disease: Evidences for the involvement of the labile iron pool level as the underlying mechanism. Neurotoxicity Research, 35(1), 71\u201382. https:\/\/doi.org\/10.1007\/s12640-018-9931-1","journal-title":"Neurotoxicity Research"},{"issue":"6","key":"5086_CR77","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1002\/ana.21203","volume":"62","author":"M Quik","year":"2007","unstructured":"Quik, M., Cox, H., Parameswaran, N., O\u2019Leary, K., Langston, J. W., & Di Monte, D. (2007). Nicotine reduces levodopa-induced dyskinesias in lesioned monkeys. Annals of Neurology, 62(6), 588\u2013596. https:\/\/doi.org\/10.1002\/ana.21203","journal-title":"Annals of Neurology"},{"issue":"10","key":"5086_CR78","doi-asserted-by":"publisher","first-page":"1398","DOI":"10.1002\/mds.25594","volume":"28","author":"M Quik","year":"2013","unstructured":"Quik, M., Mallela, A., Ly, J., & Zhang, D. (2013). Nicotine reduces established levodopa-induced dyskinesias in a monkey model of Parkinson\u2019s disease. Movement Disorders, 28(10), 1398\u20131406. https:\/\/doi.org\/10.1002\/mds.25594","journal-title":"Movement Disorders"},{"key":"5086_CR79","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1146\/annurev.pharmtox.47.120505.105214","volume":"47","author":"JA Dani","year":"2007","unstructured":"Dani, J. A., & Bertrand, D. (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Annual Review of Pharmacology and Toxicology, 47, 699\u2013729. https:\/\/doi.org\/10.1146\/annurev.pharmtox.47.120505.105214","journal-title":"Annual Review of Pharmacology and Toxicology"},{"issue":"7","key":"5086_CR80","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1016\/j.tins.2005.04.009","volume":"28","author":"R Giniatullin","year":"2005","unstructured":"Giniatullin, R., Nistri, A., & Yakel, J. L. (2005). Desensitization of nicotinic ACh receptors: Shaping cholinergic signaling. Trends in Neurosciences, 28(7), 371\u2013378. https:\/\/doi.org\/10.1016\/j.tins.2005.04.009","journal-title":"Trends in Neurosciences"},{"issue":"2","key":"5086_CR81","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/s0197-4580(02)00065-9","volume":"24","author":"H Braak","year":"2003","unstructured":"Braak, H., Del, T. K., Rub, U., de Vos, R. A., Jansen, S. E., & Braak, E. (2003). Staging of brain pathology related to sporadic Parkinson\u2019s disease. Neurobiology of Aging, 24(2), 197\u2013211. https:\/\/doi.org\/10.1016\/s0197-4580(02)00065-9","journal-title":"Neurobiology of Aging"},{"key":"5086_CR82","doi-asserted-by":"publisher","unstructured":"Braak, H., Muller, C. M., Rub, U., Ackermann, H., Bratzke, H. & de Vos, R. A., et al. (2006). Pathology associated with sporadic Parkinson\u2019s disease--Where does it end? J Neural Transm Suppl(70), 89\u201397. https:\/\/doi.org\/10.1007\/978-3-211-45295-0_15","DOI":"10.1007\/978-3-211-45295-0_15"},{"issue":"6","key":"5086_CR83","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1002\/jat.3776","volume":"39","author":"A Nakayama","year":"2019","unstructured":"Nakayama, A., Yoshida, M., Kagawa, N., & Nagao, T. (2019). The neonicotinoids acetamiprid and imidacloprid impair neurogenesis and alter the microglial profile in the hippocampal dentate gyrus of mouse neonates. Journal of Applied Toxicology, 39(6), 877\u2013887. https:\/\/doi.org\/10.1002\/jat.3776","journal-title":"Journal of Applied Toxicology"},{"issue":"Pt 1","key":"5086_CR84","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1111\/j.1469-7793.2001.00089.x","volume":"536","author":"L Maggi","year":"2001","unstructured":"Maggi, L., Sher, E., & Cherubini, E. (2001). Regulation of GABA release by nicotinic acetylcholine receptors in the neonatal rat hippocampus. Journal of Physiology, 536(Pt 1), 89\u2013100. https:\/\/doi.org\/10.1111\/j.1469-7793.2001.00089.x","journal-title":"Journal of Physiology"},{"issue":"2","key":"5086_CR85","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.atherosclerosis.2012.07.041","volume":"225","author":"N Santanam","year":"2012","unstructured":"Santanam, N., Thornhill, B. A., Lau, J. K., Crabtree, C. M., Cook, C. R., Brown, K. C., et al. (2012). Nicotinic acetylcholine receptor signaling in atherogenesis. Atherosclerosis, 225(2), 264\u2013273. https:\/\/doi.org\/10.1016\/j.atherosclerosis.2012.07.041","journal-title":"Atherosclerosis"},{"issue":"3","key":"5086_CR86","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.etap.2007.10.034","volume":"25","author":"S Neogy","year":"2008","unstructured":"Neogy, S., Das, S., Mahapatra, S. K., Mandal, N., & Roy, S. (2008). Amelioratory effect of Andrographis paniculata Nees on liver, kidney, heart, lung and spleen during nicotine induced oxidative stress. Environmental Toxicology and Pharmacology, 25(3), 321\u2013328. https:\/\/doi.org\/10.1016\/j.etap.2007.10.034","journal-title":"Environmental Toxicology and Pharmacology"},{"issue":"4","key":"5086_CR87","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1002\/ptr.2073","volume":"21","author":"V Vijayan","year":"2007","unstructured":"Vijayan, V., & Helen, A. (2007). Protective activity of Bacopa monniera Linn. on nicotine-induced toxicity in mice. Phytother Res, 21(4), 378\u2013381. https:\/\/doi.org\/10.1002\/ptr.2073","journal-title":"Phytother Res"}],"container-title":["Applied Biochemistry and Biotechnology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12010-024-05086-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12010-024-05086-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,10]],"date-time":"2025-05-10T07:01:48Z","timestamp":1746860508000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12010-024-05086-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":87,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["5086"],"URL":"https:\/\/doi.org\/10.1007\/s12010-024-05086-z","relation":{},"ISSN":["0273-2289","1559-0291"],"issn-type":[{"type":"print","value":"0273-2289"},{"type":"electronic","value":"1559-0291"}],"subject":[],"published":{"date-parts":[[2025,1,16]]},"assertion":[{"value":"12 November 2024","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 January 2025","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was approved by the Experimental Animal Ethics Committee of the Institute of Medical Biology, Chinese Academy of Medical Sciences (DWSP202203024). All methods were carried out in accordance with relevant guidelines and regulations.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical Approval"}},{"value":"All authors have their consent to participate.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to Participate"}},{"value":"All authors have their consent to publish their work.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for Publication"}},{"value":"The authors declare no competing interests.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}]}}